MORC3 and interstitial lung disease: The findings reflected in France and the United States are also similarly reflected in a Chinese cohort that identified 17 patients with anti-NXP2 antibodies of which 5 patients developed ILD in a predominantly mixed NSIP + OP pattern on HRCT (64).